RxMapper Revenue and Competitors

RxMapper, developed in collaboration with Mayo Clinic, is a DNA-guided medication therapy management platform designed to: • Keep patients safe, • Give providers best-in-class precision drug information, • Save money for employees, employers, and health plans. Background: Medications don't work the same for all people. Patients only get prescribed the optimal drug and dose about 50% of the time. We built a platform to solve for that, it won awards at Mayo Clinic, a provisional patent was filed, and was commercialized into RxMapper. RxMapper integrates with current PBMs, Health Plans, and Employers to provide transparency into drug efficacy and costs. We up your game in pharmacy benefits and provide a high-touch, easy-to-implement service for your members. Built with AI and backed by the best available science and provider consult, RxMapper will keep your members safe and informed about their medications. We make pharmacy benefits personal: RxMapper provides best-in-class pharmacogenomic sequencing and analysis to help members understand their medications at the biological level. We combine that with end-to-end tools to provide and integrate within current care channels. We provide whole exome and whole genome sequencing at lower prices than companies offering just 10-20 gene panels. Take the guesswork out of your pharmacy and healthcare spend: Medication therapy management keeps members healthy, and saves payers money. RxMapper's insights kick that up a notch. We are so confident that RxMapper will reduce healthcare spend for prospective clients, that we guarantee savings.